Introduction
Benign breast disease -BBD is a spectrum of diseases ranges from disorder to disease. Vast majority of breast lesions are benign. BBD constitute a heterogeneous group of lesions including developmental abnormalities, inflammatory lesions, epithelial and stromal proliferation, and neoplasms. Benign breast lesions present with a lump in the breast, pain, and nipple discharge. Most benign breast lesions occur in an age group of 35-45 years, incidentally it is also an age group of cancer. Presence of lump is a major concern to both patient and clinician because lump can likely to be malignant. Prime objective of a clinician is to rule out malignancy since breast cancer is most common malignant tumour in women however, benign breast lesions are more frequent than malignant lesions (1, 2) . Most benign lesions are easily diagnosed by clinical examination. Ultrasound, mammography will help in the diagnosis of suspected benign lesions. FNAC, core needle biopsy and /or excision biopsy will confirm the diagnosis. All fibro adenoma lesions are treated by excision. Wide local excision is the choice in case of fibrocystic disease of the breast when suspected as malignant, wide local excision to mastectomy is preferred choice in case of phyllodes tumour.
II.
Aims and objectives
1.
To assess the prevalence of benign breast lesions in our area 2. To assess mode of presentation of BBD 3. To assess risks of developing subsequent cancer from benign lesions of the breast.
Type of Study:
Retrospective/prospective study from January 2013 to December 2015. Place of study: The study was undertaken in the Department of General Surgery, MediCiti Institute of Medical Sciences, Ghanpur, Medchal, Telangana State -India.
III. Material and Methods
The data obtained from MRD, MediCiti Institute of Medical Sciences, a tertiary care hospital, Ghanpur, Medchal Mandal RR District. Telangan State, India. The data was compiled from patients who admitted with breast lesions, in the department of general surgery, from 2013 January to 2015 December. In the same period we admitted 1438 women patients for various diseases out of which 145 turned out as breast lesions, out of which 100 cases were diagnosed as benign breast neoplasms. Rest 45 cases were diagnosed as breast abscesses and carcinomas. As per our observation, most common benign lesions was fibroadenoma (70%) followed by fibrocystic disease (20%) and phyllodes tumour (08%). We had come a crossed three fibro adenoma variants, one juvenile fibro adenoma, two giant fibro adenomas and one lactating adenoma. We had also come a crossed one adenomyoepithelioma which is a rare benign tumour of the breast. We included one plasma cell mastitis (though inflammatory swelling) in this study because it was presenting as diffuse hard mass where it was difficult differentiate from carcinoma of the breast. One cystic lesion also we come a crossed
IV. Observation
Prevalence rate of benign breast neoplasms is 68% among all breast disease and prevalence rate of BBD is 6.9% among all diseases of women. BBD is more common in 3 rd and 4 th decade of life (65%). Left breast (60%) is more commonly involved than the right breast (40%). Lump in the breast was most common presentation (80%), definite palpable lump (100%) was a feature in fibro adenoma, phyllodes tumour and adenomyoepithelioma however, fibrocystic disease presented as lumpy breast. Lump was located in the upper and outer quadrant of the breast (64%) followed by lower outer (26%) and upper inner quadrants (10% 
V. Discussion
Benign breast disease (BBD) constitutes a heterogeneous group of lesions that include developmental abnormalities, inflammatory lesions, epithelial and stromal proliferative and benign neoplasms. BBD is most common problem among woman with a prevalence rate of 68% among all breast lesions. General prevalence rate among all diseases of women is 6.9%. Benign breast lesions are more frequent than malignant lesions (1, 2) .
BBD starts to rise in second decade of life, peaks in the third decade and declines thereafter, while incidence of carcinoma breast increases as age advances (1, 2) . Fibro adenoma can present in young age group, less common in middle age group. Fibrocystic disease, phyllodes tumor and other rare tumors like adenomyoepithelioma commonly present in 3 rd and 4 th decade of life. In our study more number of BBD presented in 3 rd and 4 th decade of life followed by 5 th decade. Lump in the breast is most common presentation (80%) followed by pain and nipple discharge.
Fibroadenoma is the most common benign neolam of the breast followed by fibrocystic disease of the breast and phyllodes tumour in order (3). Peak incidence occurs between the age group of 15 to 35 years. Fibroadenoma is thought to represent as a group of hyperplastic breast lobules called "aberrations of normal development and involution" (4). We observed different mode of presentation in young and, older individuals. The fibroadenoma occurring in young individuals is superficially placed in the breast, harder, multiple and sometimes bilateral. The fibroadenoma occurring in older people is soft, deeply placed, single and unilateral.
The neoplasm is hormone-dependent, that increases in size during lactation and pregnancy, and involutes along with rest of the breast in peri menopausal period (5). This phenomenon is particularly observed in lactating adenoma. The risk of development of fibroadenoma is claimed with usage of oral contraceptive pills before 20 years of age (5) . We have come a crossed four fibro adenoma variants, one juvenile fibro adenoma, two giant fibro adenomas and one lactating adenoma. Complex fibro adenoma is a risk factor for development of breast cancer (6) . Fibro adenomas in older women or in a women with a family history of breast cancer has higher incidence of developing breast cancer (7) .
Fibrocystic disease, patient presents with lumpy breast rather classical lump. Pain (15%) is the second most complaint followed by nipple discharge (05%). Pain is predominant feature in some individuals and it is unbearable, needs immediate attention. Treating pai is not a easy job. Although the exact pathogenesis of the entity is not clear, hormonal imbalance, particularly oestrogen predominance over progesterone seems to play an important role in its development (8, 9 , and 10). Both ductal and lobular hyperplasia has relative risk factor for development of cancer breast, risk of developing malignancy from various studies ranging from 1.9 to 13.0% (11, 12) . Radial scars on mammogram are nonspecific and may mimic as carcinoma. FNAC in such cases cannot rule out malignancy. Core biopsy is better over FNAC however excision biopsy is advised to have pool proof diagnosis (13) (14) (15) (16) . We excised one such lesion which was reported as BIRADS4 on mammogram, speculated with radial scaring, turned out as duct cell carcinoma of the breast.
Phyllodes tumour is third most common benign tumour of the breast in our study which is rapidly enlarging tumour, boselated surface with engorged veins. It is spectrum of disease ranging from fibro adenoma to benign phyllodes, metastasising benign and malignant phyllodes. Large rapidly growing and recurrent phyllodes tumours are likely to be malignant and may present with pain. Out of our eight Phyllodes tumours three turned out as malignant (38%) and are all sarcomas. Adenomyoepithelioma is very rare benign tumour of the breast. Clinically it is difficult to differentiate from carcinoma of the breast as it mimic as malignant lump with enlarged axillary lymph nodes in a middle aged woman. Recurrence rate is also high after wide excision. Most occasion patient need mastectomy.
FNAC will confirm the diagnosis in case of fibro adenoma, various studies show with average 86% specificity and 99% sensitivity. Mammogram and less extent USG breast will aid in the diagnosis of fibrocystic disease and guided biopsy either FNA or core biopsy firm doubtful areas will confirm the diagnosis. Excision biopsy is mandate in case of mammographic findings are BIRADS 4&5 lesions, reported malignant rate in such case is as high as 50-90% (13, 14) .
Treatment: excision is the treatment of the choice in case of fibroadenoma however, USG guided cryoablation is advised, who does not want surgery (17) . Fibrocystic disease is treated conservatively. Biopsy (either guided or wide excision) is advised from doubtful areas on mammography with presence of micro calcification, distorted breast architecture and radial scarring. Phyllodes tumour pose considerable problem in treatment. Wide excision is treatment of choice in small lesions. The lesion > 5cm need wide excision and large and recurring tumours require mastectomy (18, 19) . We did mastectomy for our three cases of malignant phyllodes. Plasma cell mastitis though sub acute inflammatory lump but clinically the lump is totally confused as malignant lesion since it presents as hard lump with presence of pae de arrange and nipple retraction. Recurrence after excision is also a problem (20) .
Prevalence Of Benign Breast Disease And Risk Of Malignancy In Benign Breast Diseases
Over all breast lump is a concerned to a patient as well as clinician, prime responsibility of a clinician is to rule out malignancy. Most benign lumps occur in cancer age group except fibro adenoma which occur in young individuals. Clinically difficult differentiate benign to malignant lumps as they closely mimics as malignant lumps, particularly adenomyoepithelioma, plasma cell mastitis. It is difficult to differentiate from benign phyllodes to malignant phyllodes. Recurring rapidly growing phyllodes tumour is likely to be malignant.
VI. Conclusion
Benign breast disease is more prevalent than malignancy of the breast and Prevalence rate is 68% among all breast disease and 6.9% among all diseases of women. Most women need treatment in their life time. Lump in the breast is a concerned to both patient and clinician and to rule out malignancy is prime concerned. Compound fibroadenoma is a risk factor for development of breast cancer otherwise diagnosis is straight forward, excision in the treatment of choice. Fibrocystic disease is troublesome to a patient as for as pain is concerned however, malignancy has to be excluded since fibrocystic disease present as diffuse lump in a middle aged woman difficult to differentiate from carcinoma. Excision biopsy is ideal in such cases. Phyllodes tumour is known for its recurrence after wide excision and there is high chance of malignancy in recurring rapidly growing tumours where mastectomy is the option. Adenomyoepithelioma and plasma cell mastitis are though rare will be confused as malignant lump since both conditions closely mimic as carcinoma breast, needs special attention in diagnosis and treatment. Recurrence is more common after wide excision therefore mastectomy may be ideal option. 
